MENTAL DISORDER IN CUSHING'S SYNDROME.
Glucocorticoid induced adrenal insufficiency.
Prete A, Bancos I.
BMJ. 2021 Jul 12;374:n1380. doi: 10.1136/bmj.n1380.
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
Hopkins RL, Leinung MC.
Endocrinol Metab Clin North Am. 2005 Jun;34(2):371-84, ix. doi: 10.1016/j.ecl.2005.01.013.
Complications of Cushing's syndrome: state of the art.
Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A.
Lancet Diabetes Endocrinol. 2016 Jul;4(7):611-29. doi: 10.1016/S2213-8587(16)00086-3. Epub 2016 May 10.
Systemic Absorption and Side Effects of Locally Injected Glucocorticoids.
Stout A, Friedly J, Standaert CJ.
PM R. 2019 Apr;11(4):409-419. doi: 10.1002/pmrj.12042. Epub 2019 Mar 29.
Stress and eating behaviors.
Yau YH, Potenza MN.
Minerva Endocrinol. 2013 Sep;38(3):255-67.
Psychiatric disorders associated with Cushing's syndrome.
Bratek A, Koźmin-Burzyńska A, Górniak E, Krysta K.
Psychiatr Danub. 2015 Sep;27 Suppl 1:S339-43.
Psychological complications of Cushing's syndrome.
Santos A, Webb SM, Resmini E.
Curr Opin Endocrinol Diabetes Obes. 2021 Jun 1;28(3):325-329. doi: 10.1097/MED.0000000000000633.
Cushing's syndrome.
Howlett TA, Rees LH, Besser GM.
Clin Endocrinol Metab. 1985 Nov;14(4):911-45. doi: 10.1016/s0300-595x(85)80083-9.
Patient reported outcomes and treatment satisfaction in patients with cushing syndrome.
Rakovec M, Zhu W, Khalafallah AM, Salvatori R, Hamrahian AH, Gallia GL, Ishii M, London NR Jr, Ramanathan M Jr, Rowan NR, Mukherjee D.
Endocrine. 2023 Jan;79(1):161-170. doi: 10.1007/s12020-022-03214-5. Epub 2022 Oct 13.
Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.
Santos A, Resmini E, Pascual JC, Crespo I, Webb SM.
Drugs. 2017 May;77(8):829-842. doi: 10.1007/s40265-017-0735-z.
